- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04149756
Persistent Weight Maintenance for 6 Months After 3 Months of Active Weight Loss
November 1, 2019 updated by: Ji-Won Lee, Gangnam Severance Hospital
An Observation Study on Maintaining Weight for 6 Months After 3 Months of Weight Loss Program
This study is intended to report changes in the weight and metabolic indicators of the subjects six months after the end of the study for adults with a risk factor of 27 kg/m2 or higher (formerly the research task name[clinicaltrial.gov;NCT03675191]).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
There was no special intervention after the previous research intervention.
After the previous research was completed, we will check the changes in the body composition and metabolic indicators over six months.
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ji-Won Lee, PhD
- Phone Number: 02-2019-3480
- Email: indi5645@yuhs.ac
Study Contact Backup
- Name: Yu-Jin Kwon, Dr
- Phone Number: 031-331-8710
- Email: digda3@yuhs.ac
Study Locations
-
-
Gyeonggi-do
-
Yongin, Gyeonggi-do, Korea, Republic of, 17046
- Recruiting
- Yongin Severance Hospital
-
Contact:
- Yu-Jin Kwon, Dr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Body mass index (BMI) more than 27kg/m2 with comorbidities or BMI more than 30kg/m2
Description
Inclusion Criteria:
- Those who have participated in the previous trial (NCT03675191) and have completed the three-month study
- Those who agreed the trial.
Exclusion Criteria:
- Those who have withdrawn the previous trial (NCT03675191)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
overweight or obese adults
overweight or obese adults who participate the trial (NCT03675191)
|
This study is an observational study for 96 people who have completed the previous weight loss program. We will check the body composition and lipid profile of the participants who voluntarily visit after 6months after the end of the study. . |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
weight
Time Frame: after 6months
|
weight changes
|
after 6months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
lipid profile
Time Frame: after 6months
|
total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride
|
after 6months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yu-Jin Kwon, Dr, Severance Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2019
Primary Completion (Anticipated)
October 30, 2019
Study Completion (Anticipated)
November 30, 2019
Study Registration Dates
First Submitted
October 31, 2019
First Submitted That Met QC Criteria
November 1, 2019
First Posted (Actual)
November 4, 2019
Study Record Updates
Last Update Posted (Actual)
November 4, 2019
Last Update Submitted That Met QC Criteria
November 1, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YI201905
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight Reduction
-
Marcus SaemannCompletedOverhydration | Dry Weight ReductionAustria
-
Medical Corps, Israel Defense ForceWithdrawnSmoking Cessation | Weight Reduction | Physical Fitness Habits | Balanced Nutrition | Reduction of StressIsrael
-
Tehran University of Medical SciencesCompletedWeight Reduction
-
National Taiwan University HospitalNot yet recruiting
-
Aga Khan UniversityCompleted
-
Northwestern UniversityCompleted
-
Chin HsuCompleted
-
Institute of Mental Health, SingaporeCompletedAntipsychotics Weight GainSingapore
-
Oslo Metropolitan UniversityCompleted
-
National University of SingaporeCompletedHealth Knowledge, Attitudes, Practice | Weight ReductionSingapore
Clinical Trials on observation of weight after 6months
-
Leiden University Medical CenterNot yet recruitingRecurrent Pregnancy Loss
-
Rothman Institute OrthopaedicsUnknownPostoperative Pain | Hip ArthroplastyUnited States
-
Europainclinics z.ú.University Hospital Bratislava; Slovak Academy of Sciences; R-CLINIC s.r.o.; Faculty...Recruiting
-
Ente Ospedaliero Cantonale, BellinzonaRecruitingLateral Malleolus FractureSwitzerland
-
Indiana Kidney Stone InstituteIndiana University School of MedicineCompleted
-
University of Alabama at BirminghamUniversity of Texas Southwestern Medical CenterRecruitingKidney StoneUnited States
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...UnknownKeratotic Nodular SizeBangladesh
-
St. Justine's HospitalUnknown
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedMalignant Pericardial EffusionJapan
-
Assuta Medical CenterRecruiting